Humacyte
PublicLast Round
Debt
Dec 16, 2025
Total Funding Raised
$696.15M
Company Overview
Humacyte (NAS: HUMA) is a biotechnology company focused on creating universally implantable bioengineered human tissues and organs to enhance patient outcomes and revolutionize medical practices.
Sector
Biotech
AI Layer
Non-AI
Keywords
Human Acellular Vessels (HAVs)Symvess™ bioengineered vascular conduitacellular tissue engineered vessel (ATEV™)universally implantable bioengineered human tissuevascular conduit for extremity arterial injuriesoff-the-shelf vascular grafthuman tissue engineering platformregenerative medical devicevascular repair for trauma centersautologous vein graft alternativehemodialysis access graftcommercial-stage biotechnology platformBiovascular Pancreas™ for Type 1 diabetes
Humacyte Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Humacyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 16, 2025 | ||||
| Private Placement | Oct 8, 2025 | ||||
| Debt | May 12, 2023 | ||||
| Reverse Merger | Aug 26, 2021 | ||||
| Strategic | Jun 11, 2018 | ||||
Grant | Sep 28, 2017 |
Humacyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Access Industries | Series B |
| U.S. Department of Defense | Grant |
| Avenue Capital Group | Debt |
| UBS O'Connor | Reverse Merger |
| OrbiMed | Reverse Merger |
| Bangkok Bank | Series B |
| California Institute for Regenerative Medicine | Grant |
Humacyte Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersDurham, North Carolina
Employee Range186
Year Founded2004
Last FundingDec 16, 2025